RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Takeda Pharmaceutical Company Limited

A collection of news and information related to Takeda Pharmaceutical Company Limited published by this site and its partners.

Top Takeda Pharmaceutical Company Limited Articles see all

Displaying items 1-5
  • Bill Harrison, Jackie Feldman Form PR Firm Third Street Media Group

    Public relations vets Bill Harrison and Jackie Feldman have launched new praisery Third Street Media Group that will focus on representing entertainment clients, consumer and lifestyle brands.
  • Takeda and Eli Lilly ordered to pay $9 billion over Actos drug

    A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos. The jury in Lafayette,...

    Takeda, Eli Lilly must pay $9 billion in punitive damages over Actos

    Takeda, Eli Lilly must pay $9 billion in punitive damages over Actos
    Drugmakers Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages after a Louisiana jury decided the companies did not disclose cancer risks of their diabetes medicine Actos. Japan-based Takeda said...

    Renee Amour & James Bottom

    Renee Amour & James Bottom
    Miss Amour engaged to James Bottom   Mrs. Albert Amour Jr. of Bakersfield, CA announced the engagement of her daughter, Miss Renee Michelle Amour to James George Bottom, son of Mr. and Mrs. Steven D. Bottom of Newport Beach, CA.  Miss Amour is a...

    Diet drug Contrave to get another shot at FDA approval

    Diet drug Contrave to get another shot at FDA approval
    The makers of the proposed weight-loss drug Contrave said this week they have taken a key first step in showing that the medication does not boost the heart and stroke risks of those taking it, and they announced plans to return to the Food and Drug...